Effects of Oral L-Carnitine Supplementation on Lipid Profile, Anemia, and Quality of Life in Chronic Renal Disease Patients under Hemodialysis: A Randomized, Double-Blinded, Placebo-Controlled Trial

Table 4

The changes of overall scores of quality of life and its physical and mental subscales in two groups.

	Carnitine				Placebo
	𝑛=24				𝑛=27
	Baseline	8th week	16th week	𝑃	Baseline	8th week	16th week	𝑃
Total SF-36	55.5±24.8	51.7±18.5	55.7±19.4	0.148	38.8±14.0	37.5±14.0	36.2±16.0	0.087
Physical subscales	56.6±23.9	51.2±18.7	52.5±18.0	0.033	36.6±12.1	36.6±12.4	34.5±13.3	0.180
Mental subscales	51.6±24.3	53.8±19.7	58.2±21.2	0.128	42.5±15.1	39.0±14.4	37.6±17.3	<0.001